Dako and Bristol-Myers partnered to develop pharmacodiagnostic tests to identify patients most likely to respond to Bristol-Myer's developmental compounds

Dako A/S

Denmark / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Bristol-Myers Squibb Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced